Zdrowie i gospodarka · 16/03/2017
FDA Corrects Notice on Patient-Focused Drug Development for Sarcopenia Meeting
The FDA is updating the location of a public meeting on patient-focused drug development for sarcopenia, originally announced in the Federal Register on December 14, 2016, and is seeking public comment on the corrected notice.